(Q38208963)

31 August 2017

title

Diagnosis and management of pheochromocytoma: a practical guide to clinicians (English)

1 reference

31 August 2017

1 reference

Joseph M Pappachan

1

1 reference

31 August 2017

Diana Raskauskiene

2

1 reference

31 August 2017

Rajagopalan Sriraman

3

1 reference

31 August 2017

Mahamood Edavalath

4

1 reference

31 August 2017

Fahmy W Hanna

5

1 reference

31 August 2017

publication date

1 July 2014

1 reference

Current Hypertension Reports

31 August 2017

published in

1 reference

31 August 2017

volume

16

1 reference

31 August 2017

issue

7

1 reference

31 August 2017

page(s)

442

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-014-0442-z

31 August 2017

exact match

0 references

cites work

1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Interactive medical case. A crisis in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Approach to the patient with an adrenal incidentaloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Clinical problem-solving. A crisis in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Clinical experience over 48 years with pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Genetics of pheochromocytoma and paraganglioma in Spanish patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Biochemical diagnosis of pheochromocytoma: which test is best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Laparoscopic adrenalectomy in pheochromocytoma: retroperitoneal approach versus transperitoneal approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Hypoglycemia induced by excessive rebound secretion of insulin after removal of pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

I-123 MIBG imaging and intraoperative localization of metastatic pheochromocytoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Radionuclide therapy in neuroendocrine tumours: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Radionuclide therapy of adrenal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Sunitinib: from rational design to clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Transcatheter arterial embolization for the treatment of liver metastases in a patient with malignant pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Malignant pheochromocytoma with liver metastasis treated by transcatheter arterial chemo-embolization (TACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Phaeochromocytomas and functional paragangliomas: clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Partial adrenalectomy: the National Cancer Institute experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Long-term outcomes of surgical treatment for hereditary pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Pheochromocytoma and pregnancy: a deceptive connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Pheochromocytoma in pregnancy: a case series and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Adrenal tumors and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Diagnosis and management of pheochromocytoma during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Outcomes of concurrent Caesarean delivery and pheochromocytoma resection in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Anesthesia for combined cesarean section and extra-adrenal pheochromocytoma resection: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Risk factors affecting operative approach, conversion, and morbidity for adrenalectomy: a single-institution series of 402 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

Long-term outcome of a large series of patients surgically treated for pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-014-0442-Z

[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas

21 January 2018

1 reference

12 December 2020

Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma

1 reference

12 December 2020

Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases

1 reference

12 December 2020

Pheochromocytoma surgery: epidemiologic peculiarities in children

1 reference

12 December 2020

Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?

1 reference

12 December 2020

Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma

1 reference

12 December 2020

Pheochromocytoma-induced cardiomyopathy

1 reference

12 December 2020

Adrenal incidentaloma

1 reference

12 December 2020

[Pheochromocytomas in adrenal medulla or extra-adrenal and multiple endocrine neoplasms:a clinicopathologic analysis of 181 cases]

1 reference

12 December 2020

Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison

1 reference

12 December 2020

Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review

1 reference

12 December 2020

Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI

1 reference

12 December 2020

Transarterial embolization and doxorubicin eluting beads-transarterial chemoembolization (DEB-TACE) of malignant extra-adrenal pheochromocytoma

1 reference

12 December 2020

Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells

1 reference

12 December 2020

10.1007/S11906-014-0442-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1047923737

0 references

1 reference